Seelos Therapeutics
SEEL
#10517
Rank
C$0.29 M
Marketcap
C$0.50
Share price
-31.49%
Change (1 day)
-98.21%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): C$5.91 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$51.35 Million, an increase over its 2022 earnings that were of -C$99.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$5.91 M-111.52%
2023 -C$51.35 Million-48.58%
2022 -C$99.84 Million14.07%
2021 -C$87.53 Million240.34%
2020 -C$25.72 Million-62.76%
2019 -C$69.06 Million587.73%
2018 -C$10.05 Million-36.54%
2017 -C$15.83 Million74.83%
2016 -C$9.05 Million-63.26%
2015 -C$24.64 Million-18.06%
2014 -C$30.07 Million46.19%
2013 -C$20.57 Million-31.67%
2012 -C$30.1 Million
2010 -C$28.2 Million448.63%
2009 -C$5.14 Million-25.83%
2008 -C$6.93 Million-45.65%
2007 -C$12.75 Million2.82%
2006 -C$12.4 Million-41.86%
2005 -C$21.33 Million-9.27%
2004 -C$23.5 Million114.92%
2003 -C$10.94 Million-70.78%
2002 -C$37.43 Million60.2%
2001 -C$23.37 Million70.3%
2000 -C$13.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA